Why this research matters
Nuclear medicine combines specialised imaging and targeted therapies to help clinicians diagnose and treat disease. Its potential across Africa is significant, but access depends on far more than a single machine.
Dr Janke Kleynhans speaks with RSD about PET/CT and SPECT/CT, radioligand therapy, radionuclide production, specialist training and the supply chains that keep services running.
The conversation shows why healthcare planning, local capacity and reliable infrastructure are as important as scientific innovation itself.
Key takeaways
- Imaging and radioligand therapy can contribute to cancer, cardiovascular and infectious-disease care.
- Reliable isotope supply chains are central to sustainable nuclear-medicine services.
- Investment in specialist training must grow alongside investment in equipment.